Eppdata

Eppdata is uniquely positioned to support the lifecycle of clinical studies with information technology development and domain specific medical expertise.

[Eppdata @eppdata_]

Congratulations! We keep up with the ratings. Promised. @CheesemakerMD @FishingNeurons @StrokeEso79453

[The TECNO @TECNO_Trial]

We’ve just enrolled the 100th patient in the #TECNO trial 💿🎉

A huge thank you to all sites, teams, and patients for making this progress possible 🙏

[Eppdata @eppdata_]

Congratulations: Great engineering and impressive results. TICI double read with full end-to-end traceability. Proud to be part of your journey! @Fie0815 @RaulNogueiraMD

[Perfuze @PerfuzeStroke]

Preliminary results from the MARRS pivotal IDE trial were presented at @SNISinfo, highlighting Millipede88 performance in acute ischemic stroke:
🔹 77% First Pass Effect for M1 occlusions
🔹 99% Delivery success
🔹 Promising safety profile

https://t.co/GXSU8PJ9dF

@Wayne_Perfuze

[Eppdata @eppdata_]

@PerfuzeStroke @SNISinfo @Wayne_Perfuze Congratulations: Great engineering and impressive results. TICI double read with full end-to-end traceability. Proud to be part of your journey!

[Eppdata @eppdata_]

ERASER is the first mechanical thrombectomy study with a primary endpoint based on predictive analytics enabling intraindividual virtual comparisons.

This innovative study design paves the way for faster, more reliable evaluations in clinical trials.

#Stroke #NeuroIntervention

[Eppdata @eppdata_]

MMA embolization reduces treatment failures in chronic subdural hematoma by over 50%.

Eppdata provided core lab services for the STEM trial.

Read more at the NEJM: https://t.co/53VvFpOsu7

Interested in advancing your research?
📩 Contact us today!

#MedicalResearch

[Eppdata @eppdata_]

Trustworthy data is the cornerstone of any successful clinical trial.

At Eppdata we're committed to :

Secure Data Handling
Standardized Imaging Protocols
Unbiased Analysis

Ready to elevate your research?

📩 Contact us today!

#dataIntegrity #corelab #MedicalResearch

[Eppdata @eppdata_]

Eppdata provided core lab services for the TENSION trial, proving that patients with large infarcts benefit from endovascular thrombectomy.

Check out recent The Lancet publication:
https://t.co/BuZ8RjAFh3

📩 Contact us to collaborate on your next neurovascular trial!

#corelab